ObvieLine Laboratorie is a French company created in 2005 that specializes in the research, development, manufacturing and distribution of hyaluronic acid (HA) dermal fillers. Laboratoire ObvieLine received their ISO 13485 certification in 2007 and was acquired by Sinclair Pharma in 2015.
ObvieLine has developed Perfectha, a complete range of hyaluronic acid fillers ideal for wrinkles correction, facial contouring and volume restoration. All Perfectha products have received CE markings to ensure patients optimal safety. Perfectha is the perfect filler, because of its unique cross-linking technology and its long-lasting results.